Orphazyme A/S
CSE:ORPHA

Watchlist Manager
Orphazyme A/S Logo
Orphazyme A/S
CSE:ORPHA
Watchlist
Price: 850 DKK 1.19% Market Closed
Market Cap: 34m DKK

Operating Margin
Orphazyme A/S

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-15.7m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Orphazyme A/S
Glance View

Market Cap
34m DKK
Industry
Biotechnology

Orphazyme A/S is a biopharmaceutical company, which engages in the development of treatment for patients living with life-threatening and debilitating rare diseases. The company develops new therapies for the treatment of a family of genetic disorders. The firm's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases. The Company’s candidate, arimoclomol, stimulates the production of the cells’ protein rescue system, the heat shock proteins, which helps the misfolded proteins to either get back to their functional shape or, if this cannot be achieved, remove them from the cells by means of the cells’ recycling system, the lysosomes, so they no longer form toxic aggregates. The firm collaborates with academic institutions in Europe and the United States.

ORPHA Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-15.7m
/
Revenue
0
What is the Operating Margin of Orphazyme A/S?

Based on Orphazyme A/S's most recent financial statements, the company has Operating Margin of 0%.

Back to Top